SCHEMBL22041597

SCHEMBL22041597

O=C(Oc1c(Br)c(Br)cc2cc(C(=O)O)c(=O)oc12)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 7/20 0.53
▸ MAOA P21397 1/20 0.46
▸ MAOB P27338 1/20 0.46
▸ MAPT P10636 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ ALOX5 P09917 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA3 P07451 1/20 0.41
▸ CA4 P22748 1/20 0.41
▸ CA6 P23280 1/20 0.41
▸ CA5A P35218 1/20 0.41
▸ CA7 P43166 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ CA14 Q9ULX7 1/20 0.41
▸ CA5B Q9Y2D0 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22041623 0.89 GPR35 (0.55) GPR35MAOAMAOBMAPTKDM4E
SCHEMBL22041589 0.84 GPR35 (0.50) GPR35MAOAMAOBMAPTKDM4E
SCHEMBL22041635 0.82 GPR35 (0.54) GPR35MAOAMAOBMAPTKDM4E
SCHEMBL22041594 0.82 GPR35 (0.47) GPR35MAOAMAOBMAPTCA12
SCHEMBL22041935 0.81 GPR35 (0.51) GPR35MAOAMAOBKDM4ECA12
SCHEMBL22041600 0.80 GPR35 (0.52) GPR35MAOAMAOBCA12CA1
SCHEMBL22041625 0.79 GPR35 (0.56) GPR35MAOAMAOBCA12CA1
SCHEMBL22041620 0.77 GPR35 (0.53) GPR35MAOAMAOBMAPTKDM4E
SCHEMBL22041604 0.76 GPR35 (0.55) GPR35MAOAMAOBCA12CA1
SCHEMBL22041599 0.76 GPR35 (0.52) GPR35MAOAMAOBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO claimed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO disclosed
Send feedback